BREAKING

Earnings Summary: Kraft Heinz’s Q4 2025 earnings decline on lower sales 5 hours ago Gilead Sciences (GILD) Q4 2025 adj. earnings decline, despite higher revenues 5 hours ago Mattel Q4 2025 Earnings Show Mixed Performance in Q4 Report 6 hours ago Key highlights from Humana’s (HUM) Q4 2025 earnings results 7 hours ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 1 day ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 1 day ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 1 day ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 2 days ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 2 days ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 2 days ago Earnings Summary: Kraft Heinz’s Q4 2025 earnings decline on lower sales 5 hours ago Gilead Sciences (GILD) Q4 2025 adj. earnings decline, despite higher revenues 5 hours ago Mattel Q4 2025 Earnings Show Mixed Performance in Q4 Report 6 hours ago Key highlights from Humana’s (HUM) Q4 2025 earnings results 7 hours ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 1 day ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 1 day ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 1 day ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 2 days ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 2 days ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 2 days ago

GILD

Gilead Sciences, Inc

$GILD NASDAQ Feb 10, 2026 Q1 2026

Pending

EPS Actual —

Revenue —

EPS Surprise —

Status Pending

Investor Toolbox

Listen to Call

Recording not yet available.

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

GILD Coverage

News Gilead Sciences (GILD) Q4 2025 adj. earnings decline, despite higher revenues Feb 11, 2026 Event Gilead Sciences, Inc (GILD) Q4 2025 Earnings Call Feb 10, 2026 Event Gilead Sciences, Inc (GILD) FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma Feb 6, 2026 Transcript Gilead Sciences, Inc (GILD) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Gilead Sciences, Inc (GILD) Q3 2025 Earnings Call Transcript Jan 22, 2026 News Gilead Sciences (GILD) Earnings: 2Q23 Key Numbers Aug 4, 2023 News Gilead Sciences (GILD) Earnings: 1Q23 Key Numbers Apr 28, 2023 Transcript Gilead Sciences Inc (GILD) Q2 2021 Earnings Call Transcript Jul 29, 2021